Iceland· IS-EU/1/13/866/003-004 & 006
Cholib
A simvastatin and fenofibrate product containing simvastatinum inn,fenofibratum inn, registered in Iceland by Viatris Healthcare Limited. The same ATC class is registered in 10 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Simvastatin and fenofibrate is registered in 10 of 19 countries.
Countries holding a registration under ATC C10BA04 (simvastatin and fenofibrate), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 6 of them publish a price we can compare per daily dose
Simvastatin and fenofibrate · ATC C10BA04
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Simvastatinum INN,Fenofibratum INN
- Manufacturer
- Viatris Healthcare Limited
- Country
- Iceland (IS)
- ATC code
- C10BA04
- ATC class
- Simvastatin and fenofibrate
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
2 interactions on record for simvastatin and fenofibrate.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Simvastatin and fenofibrate · interactions on record
2 records
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Simvastatin and fenofibrate in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCHOLIBVIATRIS HEALTHCARE LIMITED, Dublin
- SwitzerlandCholib
- FinlandCholibViatris Healthcare Limited
- United KingdomCholib 145mg/20mg tabletsViatris UK Healthcare Ltd
- NetherlandsCholib 145 mg/20 mg filmomhulde tablettenViatris Healthcare Limited
- PolandCholibViatris Healthcare Limited
- SwedenCholib 145 mg/20 mg Filmdragerad tablettViatris Healthcare Limited
- SpainCholib 145 mg/20 mg comprimidos recubiertos con peliculaMylan Ire Healthcare Limited
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Liechtenstein · Cholib
- Norway · Cholib
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4fc07c81-3963-4fbf-999d-391e4baf3916 GET /v1/drugs/4fc07c81-3963-4fbf-999d-391e4baf3916?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmuhúðuð tafla",
"source": "lyfjastofnun",
"atc_raw": "C10BA04",
"marketed": false,
"strength": "145 mg/40 mg",
"ma_number": "EU/1/13/866/003-004 & 006",
"substance": "Simvastatinum INN,Fenofibratum INN",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt",
"ma_issued_serial": "41512"
}See everything about simvastatin and fenofibrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.